"Jan. 1, 2013 -- Overall, people who carry a few extra pounds tended to live longer than those who are either normal weight or very obese, new research shows.
The review, of 97 studies that included a combined 2.88 million people, ques"...
IONAMIN Capsules are indicated as a short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification, and caloric restriction in the management of exogenous obesity for patients with an initial body mass index ≥ 30 kg/m², or ≥ 27 kg/m² in the presence of other risk factors (e.g., hypertension, diabetes, hyperlipidemia).
Below is a chart of Body Mass Index (BMI) based on various heights and weights.
BMI is calculated by taking the patient's weight, in kilograms (kg), divided by the patient's height, in meters (m), squared. Metric conversions are as follows: pounds ÷ 2.2 = kg; inches x 0.0254 = meters.
BODY MASS INDEX (BMI), kg/m² Height (feet,
The limited usefulness of agents of this class (see Actions) should be measured against possible risk factors inherent in their use such as those described below.
DOSAGE AND ADMINISTRATION
One capsule daily, before breakfast or 10-14 hours before retiring. For individuals exhibiting greater drug responsiveness, IONAMIN '15' will usually suffice. IONAMIN '30' is recommended for less responsive patients. IONAMIN is not recommended for use in pediatric patients under 16 years of age.
IONAMIN Capsules should be swallowed whole.
IONAMIN (phentermine resin) Capsules are available in two strengths:
15 mg, yellow/grey capsules, imprinted with “IONAMIN 15.”
NDC 53014-903-71 Bottle of 100's
NDC 53014-903-84 Bottle of 400's
30 mg, yellow/yellow capsules, imprinted with “IONAMIN 30.”
NDC 53014-904-71 Bottle of 100's
NDC 53014-904-84 Bottle of 400's
Dispense in a tight container. Store at 25°C (77°F); excursions permitted to 15°-30°C (59°-86°F) [See USP Controlled Room Temperature]. Keep out of the reach of children.
Manufactured for: UCB, Inc., Smyrna, GA 30080 USA. Rev. 12/2012This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 1/2/2013
Additional Ionamin Information
Ionamin - User Reviews
Ionamin User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.